Intranasal Leukemia Inhibitory Factor Attenuates Gliosis and Axonal Injury and Improves Sensorimotor Function After a Mild Pediatric Traumatic Brain Injury.

Neurotrauma Rep · 2023 · PMC10122240 · PMID 37095853

Europe PMC DOI

hedged sentences

0.0580

closest p · 1.2× alpha

0.0580

boldest claim

The sentences

a strong trendp = 0.058so close (0.05 < p ≤ 0.1)

However, there was a strong trend toward decreased C6T expression in the IN-LIF Rx group compared to IN-vehicle ( p = 0.058; Supplementary Fig.

also in 1,158 other papers

an encouraging trendno p-value reported

Whereas a 20-ng dose showed an encouraging trend toward reducing sensorimotor dysfunction, doubling the dosage to 40 ng noticeably improved neurological function.

also in 111 other papers

did not reach statistical significanceno p-value reported

The 20-ng IN-LIF Rx showed a trend toward improving behavioral outcomes, but did not reach statistical significance.

also in 28,709 other papers

showed a trendno p-value reported

The 20-ng IN-LIF Rx showed a trend toward improving behavioral outcomes, but did not reach statistical significance.

also in 15,197 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.